PUTRAJAYA: The National Pharmaceutical Regulatory Agency (NPRA) has approved a variation application for the extension of the shelf life of seven Covid-19 vaccine products from April 28 to Dec 20 last year.
The Health Ministry’s Pharmacy Services senior director, Norhaliza A Halim, announced the new shelf life for the products, namely Comirnaty (Pfizer), CoronaVac (Sinovac) and Convidecia (Cansino), in a detailed statement yesterday.
Already a subscriber? Log in.
Save 30% for ads-free and full access now!

Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.